DOUBEK, Michael, Šárka POSPÍŠILOVÁ and Jiří ŠTIKA. Sada pro detekci mutací asociovaných s myelodysplastickým syndromem a chronickou myelomonocytární leukemií (Kit for detecting mutations associated with myelodysplastic syndrome and chronic myelomonocytic leukemia). 2020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Sada pro detekci mutací asociovaných s myelodysplastickým syndromem a chronickou myelomonocytární leukemií
Name in Czech Sada pro detekci mutací asociovaných s myelodysplastickým syndromem a chronickou myelomonocytární leukemií
Name (in English) Kit for detecting mutations associated with myelodysplastic syndrome and chronic myelomonocytic leukemia
Authors DOUBEK, Michael (203 Czech Republic, guarantor, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Jiří ŠTIKA (203 Czech Republic, belonging to the institution).
Edition 2020.
Other information
Original language Czech
Type of outcome Legally protected outcomes
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW odkaz na stránku ÚPV
RIV identification code RIV/00216224:14740/20:00114916
Organization unit Central European Institute of Technology
Keywords (in Czech) myelodysplastický syndrom; chronická myelomonocytární leukemie
Keywords in English myelodysplastic syndrome; chronic myelomonocytic leukemia
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Daniela Tršová, Ph.D., učo 242921. Changed: 12/4/2021 10:01.
Abstract
Předkládané technické řešení poskytuje sadu 5'-biotinylovaných (obsahují biotin na 5' konci) specifických sond pro detekci mutací asociovaných s myelodysplastickým syndromem (MDS) a chronickou myelomonocytární leukémií (CMML).
Abstract (in English)
The present invention provides a set of 5'-biotinylated (containing biotin at the 5 'end) specific probes for the detection of mutations associated with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML).
Links
TE02000058, research and development projectName: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
PrintDisplayed: 28/8/2024 16:54